Tele: 561.316.3330
Breaking Medical Device News

Wednesday, September 22, 2021

MEDICAL DEVICE NEWS MAGAZINE

A DIGITAL PUBLICATION FOR THE PRACTICING MEDICAL SPECIALIST, INDUSTRY EXECUTIVE AND INVESTOR
HomeARTICLESLorcan Redmond, Professional Tri-Athlete Uses Signia Active to Optimize Performance in All Situations

Lorcan Redmond, Professional Tri-Athlete Uses Signia Active to Optimize Performance in All Situations

Lorcan Redmond appreciates the outstanding sound quality provided by Signia Active, which is complemented by its all-new state-of-the-art Bluetooth streaming option, allowing him to listen to his music, watch videos from his phone and take phone calls with the audio feeding direct into the device all while he is on the go. View his video here.

Signia ActiveWearing Signia Active hearing aids means Lorcan Redmond can now stand on the starting line with 70 other triathletes and hear the subtle sounds many of us take for granted. He can ride a bike on an open road, listen to music and hear if there are cars behind him. He can clearly hear the instructions of his coach and not miss conversations with his teammates, family, and friends.

“With a product like Signia Active, there is no excuse to not act on hearing loss and get what you need to help you live a fuller life,” Lorcan Redmond concludes. “The technology is so great that I put these in and think I’m wearing headphones, but I can just hear a lot better.”

Signia Active has been a game-changer for Lorcan Redmond, both personally and professionally, making him more confident, determined, and open about his hearing loss. He is currently training for the World Championships, scheduled for the end of this year, with the ultimate goal of heading to Birmingham next year for the 2022 Commonwealth Games.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

FDA Authorizes Software that Can Help Identify Prostate Cancer

The software is called Paige Prostate and is compatible for use with slide images that have been digitized using a scanner.

Shannon Lantzy MedCrypt New VP of Consulting

"I met Shannon at a healthcare-related event several years ago and was immediately impressed with her passion and drive to move healthcare into a digital future," said Mike Kijewski, CEO of MedCrypt.

Mark Foster Joins Xenocor BOD

Foster is a versatile and visionary C-Suite executive who brings 20 years of general management and leadership experience from both venture-backed growth-stage organizations and world-class medical device companies

Hinge Health Acquires the Most Advanced Computer Vision Technology for Tracking Human Motion

CEO Daniel Perez explained, “We won’t stop investing in technology to deliver the most patient-centered digital clinic that improves member experience and outcomes while reducing costs. wrnch allows us to take a giant leap forward in all respects.”

Dale W Wood Congratulates the Huma Team on Raising $130 Million

Major health and technology companies across the world have committed upwards of $130 million to Huma Therapeutics, the health-tech company backed by Dale Ventures.

Rhaeos Awarded $4 Million NIH SBIR Grant

Under the NIH SBIR grant, Rhaeos will leverage their existing wireless sensor hardware to provide additional quantitative flow data to the clinician, giving insight into this currently inaccessible and highly relevant shunt performance metric.

Gynesonics Announces FDA Clearance of Next Generation Sonata System

“This clearance brings significant system improvements that expand the location of fibroids that can be treated while allowing the physician to control all aspects of the treatment from within the sterile field,” said Jiayu Chen, Ph.D. Vice President, Engineering and Advanced Technologies at Gynesonics.

Blackrock Neurotech Invests In Groundbreaking Auditory Nerve Implant With University Of Minnesota And MED-EL

The new investment will enable the development and translation of a new ANI through preclinical studies and later, a pilot clinical trial, where the ANI is then implanted in up to three deaf patients.

By using this website you agree to accept Medical Device News Magazine Privacy Policy